Involvement of intestinal microbiota derived secondary bile acids in the patho-physiology of inflammatory baowel disease and the expression of UGT by intestinal epithelial cells.
Involvement of intestinal microbiota derived secondary bile acids in the patho-physiology of inflammatory baowel disease and the expression of UGT by intestinal epithelial cells.
批准号:
14570462
负责人:
FUJIYAMA Yoshihide
金额:
$1.92万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2004
中文摘要
在本研究项目中,利用t-RFLP分析显示了炎症性肠病患者肠道微生物区系的新方面,即溃疡性结肠炎患者的t-RFLP谱显示出与正常人明显不同的独特谱。用上皮电阻法测定二次胆汁酸阻断粘膜屏障的机制主要依赖于氧自由基的合成,推测XO参与了上信号通路,ERK1/2、PI3K、p38MAPK和MLCK参与了ROS合成的下游信号通路。将UGT1A3基因导入Caco-2细胞,可抑制胆石酸诱导的IL-8mRNA表达,提示溃疡性结肠炎中独特的肠道微生物区系所产生的胆汁酸成分改变可能在IBD的发病机制中发挥了新的作用。
英文摘要
In this research project, new aspect of intestinal microbiota in patients with inflammatory bowel disease has been demonstrated using t-RFLP analysis, i.e., the t-RFLP profile of patients with ulcerative colitis showed a unique profile which was apparently different from that of normal individuals. The major mechanism of interruption of mucosal barrier induced by secondary bile acids using ransepithelial electrical resistance determination method was depend on the synthesis of radical oxygen species, and it was estimated that XO was involved as upper signaling pathway and ERK1/2,PI3K,p38MAPK and MLCK were involved as down-stream signaling pathway of ROS synthesis. Transfection of UGT1A3 to CaCo-2 cells diminished IL-8 mRNA expression induced by lithocholic acid.These observations are indicative that alterations of bile acid composition produced by an unique intestinal microbiota profile in ulcerative colits might play a novel pathoetiological role in IBD.
期刊论文(45)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Bamba T, Kanauchi O, Andoh A, Fujiyama Y.: "A new prebiotic from germinated barley foodstuff for nutraceutical treatment of ulcerative colitis"J. Gastroenterol Hepatol. 17(8). 818-824 (2002)
Bamba T、Kanauchi O、Andoh A、Fujiyama Y.:“一种来自发芽大麦食品的新型益生元,用于营养治疗溃疡性结肠炎”J.
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Suppression of interleukin-1beta- and tumor necrosis factor-alpha-induced inflammatory responses by leukocytapheresis therapy in patients with ulcerative colitis.
通过白细胞去除疗法抑制溃疡性结肠炎患者的白细胞介素-1β-和肿瘤坏死因子-α诱导的炎症反应。
DOI:
--
发表时间:
2004
期刊:
J Gastroenterol. 39
影响因子:
--
作者:
[Andoh A他8名, Fujiyama Y(9番目)]
通讯作者:
Fujiyama Y(9番目)
DOI:
10.1111/j.1348-0421.2005.tb03633.x
发表时间:
2005-01-01
期刊:
MICROBIOLOGY AND IMMUNOLOGY
影响因子:
2.6
作者:
[Bamba, H, Ishigaki, H, Ogasawara, K]
通讯作者:
Ogasawara, K
Ogawa A 他4名 Fujiyama Y(5番目): "Neutralization of interleukin-17 aggravates dextransulfate sodium-induced colitis in mice."Clin Immunol.. 110巻1号. 55-62 (2004)
Okawa A 和其他 4 人 Fujiyama Y(第 5 期):“白细胞介素 17 的中和会加重小鼠右旋硫酸钠诱导的结肠炎。”Clin Nutrition.. Vol. 110,No. 1. 55-62 (2004)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Andoh A 他3名 Fujiyama Y(4番目): "Epimorphin expression in human colonic myofibroblasts."Int J Mol Med.. 13巻1号. 57-61 (2004)
Andoh A 和其他 3 人 Fujiyama Y(第 4 期):“人结肠肌成纤维细胞中的表吗啡表达。” Int J Mol Med.. Vol. 13,No. 1. 57-61 (2004)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 23 条
Development of new therapeutic agents for inflammatory bowel disease based on the dendritic cell regulation via Dectin-1
-
批准号:22590697
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.91万
-
财政年份:2010
-
负责人:FUJIYAMA Yoshihide
-
依托单位: